Short-acting B2 Agonists - Global and China Top Players Market Share and Ranking 2023

According to YH Research, the global market for Short-acting B2 Agonists should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. 

By country

China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Short-acting B2 Agonists market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Short-acting B2 Agonists market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. 

By segment

COPD grew percent to account for percent of the total market sales, and Asthma grew percent. 
Short-acting B2 agonists (SABAs) are albuterol, levalbuterol, metaproterenol, and terbutaline, and they are prescribed for bronchospasm caused by COPD, bronchial asthma, or emphysema. 

This report studies and analyses global Short-acting B2 Agonists status and future trends, helps the client to determine the Short-acting B2 Agonists market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Short-acting B2 Agonists, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year. 

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. 

To assess the competitive environment within the market including supplier revenue, market share, and company profiles. 
Highlights 

(1) Global Short-acting B2 Agonists market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units) 

(2) Global Short-acting B2 Agonists sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units) 

(3) China Short-acting B2 Agonists sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units) 

(4) Global Short-acting B2 Agonists key consuming regions, consumption quantity, consumption value and demand structure 

(5) Global Short-acting B2 Agonists key producing regions, capacity, production, and year over year growth 

(6) Short-acting B2 Agonists industry chains, upstream, midstream and downstream 

Market segment by players, this report covers 
Bayer AG 
Teva 
Roche 
Viatris 
GSK 
Cipla Limited 
Johnson & Johnson 
Merck 

Market segment by Type, covers 
Albuterol 
Metaproterenol 
Levalbuterol 
Other 

Market segment by Application, can be divided into 
COPD 
Asthma 
Other 

Market segment by regions, regional analysis covers 
North America (United States, Canada, and Mexico) 
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe) 
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific) 
South America (Brazil, Rest of South America) 
Middle East & Africa 

Chapter 1: to describe Short-acting B2 Agonists product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies. 

Chapter 2: Global Short-acting B2 Agonists market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023 

Chapter 3: China Short-acting B2 Agonists market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023 

Chapter 4: Global key producing regions of Short-acting B2 Agonists, percent & CAGR, 2018-2029 

Chapter 5: Short-acting B2 Agonists industry chain, upstream, medium-stream, and downstream. 

Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029 

Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029 

Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029 

Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029 

Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin. 

Chapter 11: Conclusions